CONGRESS NEWS

Highlights of the European Neuroendocrine Tumour Society (ENETS) Congress

BJMO - volume 14, issue 6, october 2020

ENETS Centre of Excellence , G. Boons , L. De Backer , M. Peeters MD, PhD, NETwerk Antwerpen-Waasland , T. Vandamme MD, W. Lybaert MD, PhD

The 17th Annual European Neuroendocrine Tumour Society (ENETS) Congress took place as a virtual meeting from March 11th until March 13th, 2020. This article will provide you with the highlights discussed at the meeting.

Read more

Masterclass On Site Neuroendocrine Tumours 2020

BJMO - volume 14, issue 4, june 2020

J. Blokken PhD, PharmD, T. Feys MBA, MSc, W. Lybaert MD, PhD

SUMMARY

On January 30-31st, 2020 the Masterclass on neuroendocrine tumours (NETs) took place in Antwerp, Belgium. This meeting was organised by NETwerk Antwerpen-Waasland (ENETS Centre of Excellence) with support from IPSEN. A broad plethora of presentations on molecular aspects, lung NETs, digestive NETs and neuroendocrine carcinomas (NECs), immunotherapy, Merkel cell carcinoma and patient-centred care were presented. This report will highlight the key messages of the symposium.

(BELG J MED ONCOL 2020;14(4):165–70)

Read more

The 22nd annual BSMO meeting 2020

BJMO - volume 14, issue 4, june 2020

J. Blokken PhD, PharmD, T. Feys MBA, MSc

SUMMARY

On the 14th and 15th of February 2020, the Belgian Society of Medical Oncology (BSMO) organised the 22nd annual BSMO meeting in Ghent. At this meeting, medical oncologists, oncologists in training and other specialists involved in the management of cancer patients again had the opportunity to gather as a community, exchange ideas and engage in cooperation.

(BELG J MED ONCOL 2020;14(4):171–7)

Read more

Geriatric oncology: Integrative Oncology – Leaving no one behind

BJMO - volume 14, issue 3, may 2020

C. Kenis PhD, L. Decoster MD, PhD

SUMMARY

The 2019 annual conference of the International Society of Geriatric Oncology took place in Geneva, Switzerland from November 14–16th. This year, the International Society of Geriatric Oncology and the International Federation on Ageing also jointly hosted a meeting at the United Nations on the development and preparation of health care professionals for the ageing population with cancer.

(BELG J MED ONCOL 2020;14(3):114–5)

Read more

Highlights of the Gastrointestinal Cancers Symposium 2020

BJMO - volume 14, issue 3, may 2020

A. Demols MD, PhD, I. Dero MD, W. Lybaert MD, PhD

SUMMARY

At the background of the Golden Gate Bridge with a view on the Pacific Ocean, the annual Gastrointestinal Cancers Symposium was held from 23rd until 25th January 2020 in the Moscone Congress Center in San Francisco, California. During this meeting, the potential of immunotherapy in the treatment of cancers from the upper and lower digestive tract was discussed, but no major breakthroughs were presented this year. In addition to immunotherapy, ASCO GI 2020 featured several interesting presentations on the molecular profiling of different types of gastro-intestinal cancers. These increased molecular insights will hopefully pave the way for a more biomarker-driven treatment approach for these tumours in the near future. In this report, the most important headlines will be discussed, with comments on the clinical relevance of the different studies.

(BELG J MED ONCOL 2020;14(3):116–25)

Read more

Post ASCO GU regional tour

BJMO - volume 14, issue 3, may 2020

T. Feys MBA, MSc

SUMMARY

On the 20th of February, BMUC again organised the post ASCO GU regional tour. During this meeting, which was simultaneously hosted at three locations throughout the country (Sint-Martens-Latem, Nijvel and Veerle), the key studies presented at this year’s ASCO GU meeting were discussed. Of note, this report will be based on the meeting held in Sint-Martens-Latem.

(BELG J MED ONCOL 2020;14(3):126–33)

Read more

3rd Annual International Oncology Leadership Conference

BJMO - volume 14, issue 2, march 2020

A. Paravati MBA, MD, D. Verhoeven MD, PhD

SUMMARY

The annual International Oncology Leadership Conference (IOLC) brings together physicians and administrative professionals from around the world to share best practices and to discuss future trends and challenges affecting the provision of cancer care. Following prior IOLC meetings in London and Milan, the conference in 2019 took place in Antwerp. Chairperson Prof. Didier Verhoeven and the planning committee organised an engaging agenda which was divided into three parts: economy, technology, and patient engagement/leadership. One of the main purposes of this conference is to compare US and European approaches and to learn from each other. Attendees from thirteen countries participated at the IOLC 2019. IOLC is presented by the Association of Cancer Executives and in partnership with Hauck & Associates, Inc. Some interesting points of the meeting are mentioned below.

(BELG J MED ONCOL 2020;14(2):84–5)

Read more
X